Altech Batteries Ltd has confirmed that its CERENERGY® sodium-chloride solid-state batteries have passed a rigorous individual cell testing program, which validates their safety and performance under a range of extreme operating conditions.
Group managing director Iggy Tan said: “These tests are crucial for evaluating potential risks, mismanagement or external factors.
Imugene Ltd has cleared the first dose level in the intravenous (IV) combination arm of its Phase 1 onCARlytics clinical trial, following Cohort Review Committee (CRC) approval. The OASIS study targets adult patients with advanced or metastatic solid tumours and will now proceed to a higher dose level as part of its planned escalation process.
This first-in-human trial aims to induce CD19 expression in solid tumours using onCARlytics, an oncolytic virus, thereby making the tumours susceptible to CD19-directed immunotherapies.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced that Johns Hopkins University has begun dosing patients in its Phase 2 clinical trial evaluating intranasal foralumab for non-active Secondary Progressive Multiple Sclerosis (na-SPMS).
This marks the third clinical site for the trial, alongside Brigham and Women’s Hospital and Yale Medical Center.
T Stamp Inc (NASDAQ:IDAI, EURONEXT:AIID) (dba Trust Stamp) said it has been selected as one of five companies to join the Mastercard Lighthouse MASSIV 2025 program.
The Mastercard Lighthouse MASSIV initiative supports technology firms developing scalable solutions for global challenges through strategic partnerships.
Challenger Energy Group PLC (AIM:CEG, OTC:BSHPF) has been approved to start trading on the OTCQB Venture Market in the United States, in a move intended to enhance access for US-based investors and improve liquidity.
On the OTC, the shares will trade under the ticker symbol 'BHSPF'.
Zinnwald Lithium PLC (LSE:ZNWD, OTC:ZNWLF) received a boost to its prospects on Wednesday after the Saxon State Government officially recognised its flagship lithium project in eastern Germany as “a project of outstanding importance”.
The state’s economics minister, Dirk Panter, said the mine plays a key role in reducing Germany and Europe’s reliance on foreign raw materials—especially lithium, which is critical to electric vehicle batteries and renewable energy storage.
Element 25 Ltd has fielded a high-level scoping study for a battery grade High Purity Manganese Sulphate Monohydrate (HPMSM) facility in Chiba Prefecture, Japan, that confirms the feasibility of the facility.
Developed under an ongoing memorandum of understanding (MoU) with Nissan Chemical Corporation and NC Tokyo Bay Corporation (NCTB), the scoping study examined the potential for E25 to construct the facility at a Tokyo Bay site – with a positive result, the parties are now moving to a more detailed investigation of the project in accordance with the MoU.